1. Shodhganga@INFLIBNET
  2. Jamia Hamdard University
  3. Department of Pharmacology
Please use this identifier to cite or link to this item: http://hdl.handle.net/10603/428111
Full metadata record
DC FieldValueLanguage
dc.coverage.spatial
dc.date.accessioned2022-12-18T12:02:34Z-
dc.date.available2022-12-18T12:02:34Z-
dc.identifier.urihttp://hdl.handle.net/10603/428111-
dc.description.abstractnewline
dc.format.extentxvi, 139
dc.languageEnglish
dc.relation
dc.rightsuniversity
dc.titleDevelopment and Investigation Of Empagliflozin Nanoformulation in Type 2 Diabetes Associated Cognitive Impairment
dc.title.alternative
dc.creator.researcherTahira Khan
dc.subject.keywordClinical Pre Clinical and Health
dc.subject.keywordPharmacology and Pharmacy
dc.subject.keywordPharmacology and Toxicology
dc.description.note
dc.contributor.guideNajmi, Abul Kalam
dc.publisher.placeDelhi
dc.publisher.universityJamia Hamdard University
dc.publisher.institutionDepartment of Pharmacology
dc.date.registered2016
dc.date.completed2022
dc.date.awarded2022
dc.format.dimensions
dc.format.accompanyingmaterialDVD
dc.source.universityUniversity
dc.type.degreePh.D.
Appears in Departments:Department of Pharmacology

Files in This Item:
File Description SizeFormat 
01 _ title page.pdfAttached File37.02 kBAdobe PDFView/Open
02_prelim pages.pdf825.32 kBAdobe PDFView/Open
03_content.pdf133.68 kBAdobe PDFView/Open
04 _ abstract.pdf73.4 kBAdobe PDFView/Open
05 _ chapter 1.pdf95.3 kBAdobe PDFView/Open
06 _chapter 2.pdf670.78 kBAdobe PDFView/Open
07 _chapter 3.pdf127.44 kBAdobe PDFView/Open
08 _chapter 4.pdf329.01 kBAdobe PDFView/Open
09 _chapter5.pdf374 kBAdobe PDFView/Open
10 _chapter 6. results.pdf1.84 MBAdobe PDFView/Open
11 _chapter 7.pdf146.31 kBAdobe PDFView/Open
12_annexures.pdf550.37 kBAdobe PDFView/Open
80_recommendation.pdf116.53 kBAdobe PDFView/Open
Show simple item record


Items in Shodhganga are licensed under Creative Commons Licence Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0).

Altmetric Badge: